Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic Open-label, Parallel-group Clinical Trial on the Effectiveness of Extract of Ginkgo Biloba Leaves Tablets as add-on to Standard of Care in Participants With Cognitive Impairment After an Acute Ischemic Stroke (GiCIIS)

NCT07220538 is registered in ClinicalTrials.gov with Dr. Willmar Schwabe GmbH & Co. KG as lead sponsor.

NCT NCT07220538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic Open-label, Parallel-group Clinical Trial on the Effectiveness of Extract of Ginkgo Biloba Leaves Tablets as add-on to Standard of Care in Participants With Cognitive Impairment After an Acute Ischemic Stroke (GiCIIS)
Lead sponsor
Dr. Willmar Schwabe GmbH & Co. KG
Phase
Phase 4
Overall status
Recruiting
Start date
November 28, 2025
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

impairment, cognitive, ischemic stroke hospitalized